Organization attributes
Venture Capital Firm attributes
Other attributes
NGN Capital is a New York City based venture capital firm. They invest in the healthcare and biotechnology companies including drug products, medical devices and healthcare services sectors. NGN Capital focuses their investments on companies they feel have the potential to achieve above average equity returns.
NGN Capital invests across maturity stages, from seed and early stage to later stage, and predominately in the United States and Europe. Their European office is in Heidelberg, Germany.
NGN Capital has invested in Exosome Diagnostics, Endosense, Small Bone Innovations, Artisan Pharma, Noxxon Pharma, Valtech Cardio, BeneChill, Aerovance, Cerapedics and Vivaldi Biosciences.
They exited their investments in Exosome Diagnostics, Small Bone Innovations, Noxxon Pharma, Santhera Pharmaceuticals, Endosense, BeneChill, Valtech Cardio and EKOS Corporation.
